MERTK as a novel therapeutic target in head and neck cancer

MLA

Johannes Brägelmann, et al. “MERTK as a Novel Therapeutic Target in Head and Neck Cancer.” Oncotarget, vol. 7, no. 22, Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0c9ab6af28697236a9fdcdb88a46be84&authtype=sso&custid=ns315887.

APA

Johannes Brägelmann, Friedrich Bootz, Christine Sanders, Glen Kristiansen, Mario C. Deng, Peter Brossart, Wenzel Vogel, Andreas Schröck, Sven Perner, Jutta Kirfel, Lynn E. Heasley, Anne von Mässenhausen, Stefan Duensing, Britta Thewes, & Angela Queisser. (2016). MERTK as a novel therapeutic target in head and neck cancer. Oncotarget, 7(22).

Chicago

Johannes Brägelmann, Friedrich Bootz, Christine Sanders, Glen Kristiansen, Mario C. Deng, Peter Brossart, Wenzel Vogel, et al. 2016. “MERTK as a Novel Therapeutic Target in Head and Neck Cancer.” Oncotarget 7 (22). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0c9ab6af28697236a9fdcdb88a46be84&authtype=sso&custid=ns315887.